Deudomperidone

DB19055InvestigationalSmall molecule

Deudomperidone is under investigation in clinical trial NCT05832151 (A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis).

Chemical structure of Deudomperidone
Formula / weight
C22H24ClN5O2 · 429.94 g/mol (avg)
Also known as
2h-benzimidazol-2-one-4,5,6,7-d4, 1-(3-(4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1-piperidinyl)propyl)-1,3-dihydro- · 3-(3-(4-(5-chloro-2-oxo-3hbenzimidazol-1-yl)-1- piperidyl)propyl)-4,5,6,7- tetradeutero-1h-benzimidazol-2- one
Code names
CIN-102

Resolves to

Compound
UNIIHN0VIB0W8WCAS2121525-08-2ChEMBLCHEMBL4594380
Structure
InChIKeyFGXWKSZFVQUSTL-GYABSUSNSA-NSMILES[2H]C1=C([2H])C([2H])=C2N(CCCN3CCC(CC3)N3C(=O)NC4=CC(Cl)=CC=C34)C(=O)NC2=C1[2H]

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Deudomperidone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In